Astronomers have discovered a “black hole star,” an extremely bright red spot in the early universe that appears to be a new type of astrophysical object. It resembles an enormous star, but its energy production is closer to what a black hole might generate.

Shoppers who use trolleys embedded with digital screens to assist trips to the supermarket spend up to a third more than those who do not, according to new research by Bayes Business School (City St George’s, University of London).

CAMBRIDGE, Mass., Aug 12 — Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or Lp(a), as a preclinical candidate (PCC) for the management of cardiovascular risks. Notably, this marks the company's 9th PCC nomination announced since 2026, showcasing the enhanced efficiency and scalability that generative AI brings to early-stage drug discovery.

A new semiconductor integration platform developed at Institute of Science Tokyo combines advanced chip packaging with high-density interconnects and improved thermal management. This combination of three complementary technologies helps overcome the key challenges in building high-performance artificial intelligence (AI) hardware. By enabling more precise chip placement, faster communication, and efficient cooling, the technology paves the way for more powerful and energy-efficient AI accelerators and high-performance computing systems.